GR3030102T3 - Aspartic acid derivatives or homologues thereof and their use in the treatment of neurological diseases. - Google Patents
Aspartic acid derivatives or homologues thereof and their use in the treatment of neurological diseases.Info
- Publication number
- GR3030102T3 GR3030102T3 GR990401184T GR990401184T GR3030102T3 GR 3030102 T3 GR3030102 T3 GR 3030102T3 GR 990401184 T GR990401184 T GR 990401184T GR 990401184 T GR990401184 T GR 990401184T GR 3030102 T3 GR3030102 T3 GR 3030102T3
- Authority
- GR
- Greece
- Prior art keywords
- phenyl
- homologues
- treatment
- thienyl
- naphthyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Otolaryngology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939324872A GB9324872D0 (en) | 1993-12-03 | 1993-12-03 | Pharmaceutical compounds |
| US08/343,817 US5589501A (en) | 1993-12-03 | 1994-11-22 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3030102T3 true GR3030102T3 (en) | 1999-07-30 |
Family
ID=26303963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR990401184T GR3030102T3 (en) | 1993-12-03 | 1999-04-30 | Aspartic acid derivatives or homologues thereof and their use in the treatment of neurological diseases. |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5589501A (el) |
| EP (1) | EP0656345B1 (el) |
| JP (1) | JPH0820564A (el) |
| AT (1) | ATE177419T1 (el) |
| CA (1) | CA2137028A1 (el) |
| DE (1) | DE69416945T2 (el) |
| DK (1) | DK0656345T3 (el) |
| ES (1) | ES2130370T3 (el) |
| GB (1) | GB9324872D0 (el) |
| GR (1) | GR3030102T3 (el) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5576323A (en) * | 1993-12-03 | 1996-11-19 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| GB9617822D0 (en) * | 1996-08-27 | 1996-10-09 | Lilly Industries Ltd | Pharmaceutical compounds |
| ES2133095B1 (es) * | 1997-03-25 | 2000-04-01 | Lilly Sa | Acidos alquilidenglutaminicos con propiedades farmaceuticas. |
| DE19801647A1 (de) | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte beta,gamma-annellierte Lactone |
| DE19801636A1 (de) | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte bicyclische Lactone |
| DE19801646A1 (de) | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte alpha,beta-annellierte Butyrolactone |
| CN100553636C (zh) | 2000-08-04 | 2009-10-28 | Dmi生物科学公司 | 二酮基哌嗪和包含它们的组合物的使用方法 |
| CN102210852B (zh) | 2003-05-15 | 2016-10-19 | 安皮奥制药股份有限公司 | T-细胞介导的疾病的治疗 |
| EP2123621A1 (de) | 2008-05-20 | 2009-11-25 | Bayer Schering Pharma Aktiengesellschaft | Neue {F-18}-markierte L-Glutaminsäure- und L-Glutaminderivate (I), ihre Verwendung sowie Verfahren zu ihrer Herstellung |
| KR101495924B1 (ko) | 2006-11-01 | 2015-02-25 | 바이엘 파마 악티엔게젤샤프트 | [ｆ-１８]-표지된 ｌ-글루탐산, [ｆ-１８]-표지된 ｌ-글루타민, 이들의 유도체 및 이들의 용도 및 이들의 제조 방법 |
| EP2123620A1 (en) * | 2008-05-20 | 2009-11-25 | Bayer Schering Pharma Aktiengesellschaft | {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them |
| WO2009146320A1 (en) | 2008-05-27 | 2009-12-03 | Dmi Life Sciences, Inc. | Therapeutic methods and compounds |
| CN102711841A (zh) * | 2009-11-17 | 2012-10-03 | 拜耳医药股份有限公司 | 碘标记的高谷氨酸和谷氨酸衍生物 |
| JP2013537195A (ja) | 2010-09-07 | 2013-09-30 | ディエムアイ アクイジション コーポレイション | 疾患の治療 |
| EP2520556A1 (en) * | 2011-05-03 | 2012-11-07 | Bayer Pharma Aktiengesellschaft | Radiolabeled amino acids for diagnostic imaging |
| CA2846598C (en) | 2011-10-10 | 2019-12-10 | Ampio Pharmaceuticals, Inc. | Treatment of degenerative joint disease |
| EA027343B1 (ru) | 2011-10-10 | 2017-07-31 | Ампио Фармасьютикалз, Инк. | Имплантируемые устройства медицинского назначения с повышенной иммунной толерантностью и способы изготовления и имплантирования |
| EA201490737A1 (ru) | 2011-10-28 | 2014-09-30 | Ампио Фармасьютикалз, Инк. | Лечение ринита |
| EP2968315B1 (en) | 2013-03-15 | 2020-06-03 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
| JP6723222B2 (ja) | 2014-08-18 | 2020-07-15 | アンピオ ファーマシューティカルズ，インコーポレイテッド | 関節病態の治療 |
| US11389512B2 (en) | 2015-06-22 | 2022-07-19 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
-
1993
- 1993-12-03 GB GB939324872A patent/GB9324872D0/en active Pending
-
1994
- 1994-11-22 US US08/343,817 patent/US5589501A/en not_active Expired - Fee Related
- 1994-11-30 CA CA002137028A patent/CA2137028A1/en not_active Abandoned
- 1994-12-02 ES ES94308952T patent/ES2130370T3/es not_active Expired - Lifetime
- 1994-12-02 DK DK94308952T patent/DK0656345T3/da active
- 1994-12-02 EP EP94308952A patent/EP0656345B1/en not_active Expired - Lifetime
- 1994-12-02 DE DE69416945T patent/DE69416945T2/de not_active Expired - Fee Related
- 1994-12-02 AT AT94308952T patent/ATE177419T1/de not_active IP Right Cessation
- 1994-12-02 JP JP6299206A patent/JPH0820564A/ja active Pending
-
1996
- 1996-09-13 US US08/713,624 patent/US5739164A/en not_active Expired - Fee Related
-
1999
- 1999-04-30 GR GR990401184T patent/GR3030102T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5589501A (en) | 1996-12-31 |
| CA2137028A1 (en) | 1995-06-04 |
| EP0656345A1 (en) | 1995-06-07 |
| EP0656345B1 (en) | 1999-03-10 |
| DK0656345T3 (da) | 1999-09-27 |
| DE69416945D1 (de) | 1999-04-15 |
| ATE177419T1 (de) | 1999-03-15 |
| ES2130370T3 (es) | 1999-07-01 |
| GB9324872D0 (en) | 1994-01-19 |
| DE69416945T2 (de) | 1999-08-12 |
| JPH0820564A (ja) | 1996-01-23 |
| US5739164A (en) | 1998-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3030102T3 (en) | Aspartic acid derivatives or homologues thereof and their use in the treatment of neurological diseases. | |
| MA22896A1 (fr) | Procede de production de n-aryl- et n-heteroarylurees utilisables comme inhibiteurs d'acylcoenzymes a:cholesterol-acyltransferase (acat) . | |
| IL110324A0 (en) | Intermediates to n-aryl and n-heteroarylamide and urea derivatives | |
| EP0767170A4 (en) | 4,6-DIARYLPYRIMIDINE DERIVATIVES AND THEIR SALTS | |
| CA2102209A1 (en) | Novel Isoxazole Derivative and Salt Thereof | |
| BG92179A (bg) | Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения | |
| CA2103590A1 (en) | Benzamide derivative | |
| ZA882931B (en) | New herbicide,its preparation and use | |
| DK0637583T3 (da) | 1-Aryloxy-3-alkylamino-2-propanol-nitratestere, anvendelse heraf og tilsvarende farmaceutisk præparat | |
| ATE114154T1 (de) | Thienotriazolodiazepine und ihre pharmazeutische verwendung. | |
| IL107315A0 (en) | 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and pharmaceutical compositions containing them | |
| AU8226891A (en) | Benzopyran derivative, production thereof, and pharmaceutical composition containing the same | |
| YU47973B (sh) | S-enantiomerni glutaramidi i postupak za njihovo dobijanje | |
| CA2038025A1 (en) | Optically active alkylenedioxybenzene derivatives and their use in therapy | |
| ES8802508A1 (es) | Procedimiento para preparar derivados alquenicos. | |
| HU9601701D0 (en) | Aromatic hydroxamic acid compounds, process for producing them and their use | |
| JPS5716855A (en) | 4-guanidinomethylcyclohexanecarboxylic acid ester and its preparation | |
| DE3887612D1 (de) | Salicylate, ihre Salze, diese enthaltende pharmazeutische Kompositionen und ihr Herstellungsverfahren. | |
| PH27481A (en) | Novel compounds | |
| FR2672800B1 (fr) | Nouvelle utilisation en therapeutique de pycnogenols pour la preparation de medicaments a activite anti-inflammatoire. | |
| LTIP1788A (en) | Novel acrylic acid salts, a process for their preparation, pharmaceutical compositions containing them and their use in medicine | |
| IT1229846B (it) | Esteri di catecolammine. | |
| ES2061535T3 (es) | Un metodo para preparar un compuesto ester de acido benzopiranopiridinacetico. | |
| DE3364087D1 (en) | Derivatives of 3-amino-1-phenoxy-2-propanol, their therapeutical use and process for their preparation | |
| JPS646244A (en) | Tertiary amine derivative, production thereof and fungicide for agriculture and garden |